- Onto Innovation recently reported that strong demand for its metrology and inspection tools in AI and advanced semiconductor packaging, supported by a record backlog and a major volume agreement with a leading HBM maker, is driving expectations for more than 30% revenue growth in advanced packaging in 2026.
- This momentum not only reinforces Onto Innovation’s role in critical AI and high‑bandwidth memory production, but also highlights how higher-margin advanced packaging tools and improving gross margins could materially reshape the mix of its core business.
- With management highlighting record advanced packaging demand and a major HBM volume agreement, we’ll now examine how this update influences Onto Innovation’s investment narrative.
AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Onto Innovation Investment Narrative Recap
To own Onto Innovation, you generally have to believe that demand for AI driven metrology and inspection, especially in advanced packaging and HBM, can support profitable growth without overextending on a few key customers. The latest update, pointing to more than 30% advanced packaging revenue growth in 2026 backed by record backlog and an HBM volume deal, reinforces that near term catalyst, while also sharpening the main risk around customer and segment concentration if that demand stumbles.
The most relevant recent announcement here is the Dragonfly G5 launch in March 2026, which targets exactly the kind of AI and HBM packaging use cases highlighted in the news. With double digit orders already committed and shipments slated to start in the second quarter of 2026, Dragonfly G5 sits at the center of Onto’s advanced packaging push, tying the company’s product roadmap directly to the same HBM and AI trends driving today’s backlog and revenue expectations.
Yet beneath this strength, investors should be aware that Onto’s growing reliance on a concentrated set of HBM and AI packaging customers could...
Read the full narrative on Onto Innovation (it's free!)
Onto Innovation's narrative projects $1.4 billion revenue and $311.2 million earnings by 2028. This requires 11.0% yearly revenue growth and an earnings increase of about $111 million from $199.9 million today.
Uncover how Onto Innovation's forecasts yield a $265.71 fair value, a 23% upside to its current price.
Exploring Other Perspectives
Some of the lowest ranking analysts were already cautious, assuming revenue would reach about US$1.7 billion and earnings US$457.0 million by 2029, which is a much tougher bar than the consensus view and reflects deeper worries about margin pressure and customer dependence that the latest HBM centric news could either ease or amplify.
Explore 5 other fair value estimates on Onto Innovation - why the stock might be worth 38% less than the current price!
The Verdict Is Yours
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Onto Innovation research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Onto Innovation research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Onto Innovation's overall financial health at a glance.
Interested In Other Possibilities?
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.
- Capitalize on the AI infrastructure supercycle with our selection of the 36 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com